Doliente, Michelle .

HRN: 05-68-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2023
CEFUROXIME 750MG (VIAL)
07/13/2023
07/13/2023
IV
750mg
LD
Complete Fracture, Close, Displaced Distal 3rd Radius Left; Oblique Fracture, Close Middle 3rd Ulna Left
07/13/2023
CEFUROXIME 750MG (VIAL)
07/13/2023
07/19/2023
IV
375mg
Q8hr
Complete Fracture, Close, Displaced Distal 3rd Radius Left; Oblique Fracture, Close Middle 3rd Ulna Left
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: